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Abstract
Background: Next-generation sequencing (NGS) is increasingly being translated into routine public health practice,
affecting the surveillance and control of many pathogens. The purpose of this scoping review is to identify and
characterize the recent literature concerning the application of bacterial pathogen genomics for public health
practice and to assess the added value, challenges, and needs related to its implementation from an
epidemiologist’s perspective.
Methods: In this scoping review, a systematic PubMed search with forward and backward snowballing was
performed to identify manuscripts in English published between January 2015 and September 2018. Included
studies had to describe the application of NGS on bacterial isolates within a public health setting. The studied
pathogen, year of publication, country, number of isolates, sampling fraction, setting, public health application,
study aim, level of implementation, time orientation of the NGS analyses, and key findings were extracted from
each study. Due to a large heterogeneity of settings, applications, pathogens, and study measurements, a
descriptive narrative synthesis of the eligible studies was performed.
Results: Out of the 275 included articles, 164 were outbreak investigations, 70 focused on strategy-oriented
surveillance, and 41 on control-oriented surveillance. Main applications included the use of whole-genome
sequencing (WGS) data for (1) source tracing, (2) early outbreak detection, (3) unraveling transmission dynamics, (4)
monitoring drug resistance, (5) detecting cross-border transmission events, (6) identifying the emergence of strains
with enhanced virulence or zoonotic potential, and (7) assessing the impact of prevention and control programs.
The superior resolution over conventional typing methods to infer transmission routes was reported as an added
value, as well as the ability to simultaneously characterize the resistome and virulome of the studied pathogen.
However, the full potential of pathogen genomics can only be reached through its integration with high-quality
contextual data.
Conclusions: For several pathogens, it is time for a shift from proof-of-concept studies to routine use of WGS
during outbreak investigations and surveillance activities. However, some implementation challenges from the
epidemiologist’s perspective remain, such as data integration, quality of contextual data, sampling strategies, and
meaningful interpretations. Interdisciplinary, inter-sectoral, and international collaborations are key for an
appropriate genomics-informed surveillance.
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Introduction
The advent and continuous improvement of sequencing
technologies, especially the shift to next-generation
sequencing (NGS), provides many opportunities for the
management of infectious diseases. Sequence informa-
tion can identify a pathogen and its specific characteris-
tics, as well as its relatedness to other pathogens.
Compared to Sanger sequencing, NGS technologies
allow a faster and cheaper way to sequence large
amounts of nucleotides. As such, NGS can be viewed as
a tool that makes whole-genome sequencing (WGS)
accessible [1]. In contrast to genotyping, where only
small parts of the genome are assessed, WGS provides
characteristics of the entire genome of the infectious iso-
lates, thereby combining maximal strain discrimination
and the ability to link the genotype with clinically and
epidemiologically relevant phenotypes [2, 3]. Sequence
variations, such as single-nucleotide polymorphisms
(SNPs), insertions/deletions, and accessory genes can be
identified following bioinformatics analyses [1]. Highly
discriminatory subtyping following WGS is accom-
plished based on either SNPs or allelic variation [5].
With decreasing costs and increasing laboratory and bio-
informatics capacities, we are currently transitioning to
genomic epidemiology, as whole pathogen genomes are
available at the level of the population [3]. Adding
genomic data to epidemiological analyses of infectious
diseases greatly benefits disease prevention and control
[1, 2]. During the last decade, NGS is no longer limited
to research settings and is being rapidly translated into
public health practice [4, 5].
This review focuses on the applications of NGS to the
population-level management of bacterial infections
(Fig. 1). This includes the use of WGS to study the re-
latedness of isolates in order to understand transmission
dynamics, to detect and control outbreaks, to monitor
trends, and to identify the emergence of new threats.
More specifically, this review discusses the applications
of pathogen genomics that lead to actionable results
from a public health point of view.
Public health activities related to infectious diseases
can be classified as outbreak investigations, control-
oriented surveillance, and strategy-oriented surveillance
[3, 6]. The main objective of an outbreak investigation is
Fig. 1 Focus of the scoping review on pathogen genomics for public health practice. Different domains in the field of infectious diseases require
access to the same pathogen genomic data. Whole-genome sequencing (WGS) has the ability to inform and improve individual patient care, by
identifying the species, determining its pathogenic potential, and testing its susceptibility to antimicrobial drugs. WGS also provides data for
public health surveillance about the relatedness of the pathogen to other strains to investigate transmission routes, monitor trends over time,
and allow the identification and control of outbreaks and new threats. Research is a knowledge driver providing reference data, methods, and a
deeper understanding about the underlying biological mechanisms to the other domains. The focus of this scoping review is on the use of WGS
as a public health tool, i.e., at the level of the population
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to investigate the possible source(s) of infection and to
implement effective and appropriate control measures to
stop its further spread. Outbreak investigations are often
hypothesis-driven and a reaction to a sudden increase in
the number of cases [7]. In contrast, surveillance is the
systematic collection, analysis, and dissemination of data
for the planning, implementation, and evaluation of
public health programs [8]. Baker et al. [6] differentiate
between control-oriented and strategy-oriented surveil-
lance, thereby providing a meaningful way to categorize
the applications of molecular/genomic tools for disease
surveillance [9]. This framework has also been adopted
in the European Centre for Disease Prevention and Con-
trol (ECDC) roadmap for integration of molecular and
genomic typing into European level surveillance and
epidemic preparedness [10]. As defined by Baker et al.
[6], the purpose of control-oriented surveillance is “to
identify each occurrence of a particular disease, hazard,
or other health-related event that requires a specific
response, and to support the delivery of an effective
intervention”. For example, control-oriented surveillance
aims at the detection of outbreaks that require a specific
response. Early outbreak detection can be achieved by
prospectively genotyping as many consecutive cases in a
population as possible to identify clusters of clonally
linked isolates [3]. Baker et al. state that strategy-
oriented surveillance aims “to provide information to
support prevention strategies to reduce population risk”
[6]. The aim is often to monitor long-term changes in
epidemiology over larger geographic and population
scales, requiring study designs that have a high degree of
representativeness [9]. Strategy-oriented surveillance can
for example detect the emergence of strains with en-
hanced virulence or drug resistance, help to identify risk
factors associated with the transmission of specific
strains, or predict the effectiveness of control programs
such as vaccination campaigns [3].
Collective experience on the use of pathogen genomics
for routine public health practice is spread across litera-
ture. WGS has been frequently used to aid outbreak in-
vestigations and routine surveillance at various levels
(i.e., local, national, and international) and in different
temporal scenarios (i.e., retrospective and prospective).
The aim of this scoping review is to identify and
characterize the recent literature concerning the applica-
tion of NGS for public health practice, by (1) conducting
a systematic search of the published literature, (2)
mapping the characteristics of the identified studies, (3)
describing the range of applications identified, and (4)
assessing the added value, challenges, and requirements
related to its implementation. The purpose is to provide
an epidemiologist’s perspective on the use of bacterial
pathogen genomics in a public health context to com-
plement previous reviews that focused on technical
aspects, bioinformatics, diagnostics, or microbiology
(i.e., the perspective of microbiologists, bioinformati-
cians, and clinicians) [2, 5, 11–16]. This review aims to
summarize the experience gained and use it to further
advance the implementation of pathogen genomics in
routine public health.
Methods
A scoping review methodology was chosen to provide
an overview of the nature and extent of the literature on
this topic via systematically searching, selecting, and
summarizing evidence, rather than a traditional system-
atic review that often focuses on specific outcomes [17].
This review was conducted according to the Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines [see Additional file 1]
[18], adapted for use in a scoping review as appropriate,
and adhering to the methodology outlined in The Joanna
Briggs Institute Manual for Scoping reviews [19]. In
addition, the framework outlined by Arksey and O’Mal-
ley [20] in their methodological paper on scoping
reviews was followed. A scoping review protocol was de-
veloped a priori to ensure reproducibility and transpar-
ency of the review methods [see Additional file 2].
Eligibility criteria
The inclusion criteria were organized following the
PCC (Population, Concept, and Context) elements.
Studies had to include at least 2 individuals with a bac-
terial infection, and NGS had to be applied on the bac-
terial isolates. Consequently, non-human studies and
case reports involving only one patient were excluded,
as well as studies focusing on the host genome. Studies
had to describe the application of NGS from a public
health perspective (i.e., population-level). Therefore, the
main study aims had to be within the context of an out-
break investigation, control-oriented surveillance, or
strategy-oriented surveillance. Studies focusing on tech-
nical aspects, applying NGS solely for individual patient
care, and using NGS primarily for research purposes
were excluded. Further, only studies applying NGS
within a real-life public health setting, as opposed to an
experimental setting, and producing an output that can
be directly translated into actionable results to benefit
public health, were included. This also included proof-
of-concept studies mimicking real-life public health
situations. Studies published between January 2015 and
September 2018 were included to consider the most
current activities in this fast-evolving field. A full list of
inclusion and exclusion criteria and a decision tree for
study selection is provided in the additional material
[see Additional files 3 and 4].
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Searching
The PubMed search engine was used to identify manu-
scripts in English published between 1/1/2015 and 4/9/
2018. In addition, reference lists of included studies and
other reviews were examined (i.e., backward snowbal-
ling). Also, forward snowballing was performed by iden-
tifying relevant documents that cited the included
studies, using the Google Scholar search engine.
Three domains were included in the search using the
PubMed search engine: “bacterial infections,” “next gen-
eration sequencing,” and “public health.” Each domain
had several search terms. Free text search and MeSH
term search were combined. The search was pre-tested
to determine the most effective balance of sensitivity
and specificity in the identification of potentially relevant
citations. The ability of the electronic search to capture
all relevant primary research was verified by hand-
searching reference lists from other reviews on the topic.
The final search string is reported in the additional ma-
terial [see Additional file 5]. The initial search was con-
ducted on March 24, 2018, and was updated on
September 4, 2018, selecting the date range “March 1,
2018, to September 4, 2018.”
Screening
A first screening phase based on titles and abstracts was
conducted [NVG], and out-of-topic studies were ex-
cluded. A second screening stage based on the full texts
was conducted in duplicate by two independent re-
viewers [NVG, TD] using a standardized eligibility form.
If no consensus could be reached between the two re-
viewers, a third reviewer [NB] helped to resolve the
disagreement.
Data extraction
Data extraction was performed by [NVG] using an ex-
traction form that was designed for the purpose of this
review through an iterative process [see Additional file
6]. Information regarding the studied pathogen, country,
year of publication, number of isolates, sampling fraction
and time orientation of the NGS analyses, setting, public
health application, study aim(s), and level of implemen-
tation was extracted from each included study. In
addition, key findings related to the use of NGS were
summarized for every study.
Data synthesis
The main characteristics were summarized in tabular
form (as per data extraction pro-forma as well as a nu-
merical summary), with an accompanying narrative sum-
mary, based on the key findings extracted from every
study, describing how the results relate to the review ob-
jective and question. The studies were categorized based
on the public health application and study aim in order
to structure the narrative summary. For the study aim,
multiple classifications per article were allowed.
Results
Search results
The study selection process is summarized as a PRISMA
flow diagram in Fig. 2. A total of 1549 studies were iden-
tified through the initial database search, hand searching,
reference checking, and other reviews. The search was
updated in September 2018, and an additional 142 arti-
cles were identified (of which 19 were included). A total
of 275 studies were included in the review.
Study characteristics
Out of the 275 included articles, 164 (60%) were out-
break investigations, 70 (25%) focused on strategy-
oriented surveillance, and 41 (15%) on control-oriented
surveillance. Almost all studies (274 out of 275) applied
NGS technologies in the context of WGS, which will
consequently be the focus for the remainder of this re-
view. Table 1 gives an overview of the general character-
istics of the included studies. Table 2 gives a deeper
insight into the different study aims. The completed ex-
traction form describing the characteristics of all in-
cluded studies is available in the additional material [see
Additional file 7].
Outbreak investigations of food- and waterborne path-
ogens mainly focused on source tracing (n = 78, 48%), in
order to identify and eliminate the source as quickly as
possible. In case of person-to-person transmission, the
outbreak investigations focused on understanding trans-
mission dynamics and reveal the spread of the pathogen
in the population, in order to interrupt transmission
chains and to prevent its further spread (n = 85, 52%).
Eleven studies (7%) reported the use of WGS to provide
feedback on key phenotypic attributes, such as virulence
genes or antibiotic resistance, in order to inform out-
break management. The majority of the outbreak inves-
tigations were performed retrospectively (n = 97, 59%),
i.e., as a proof-of-concept and/or to improve future pre-
paredness by addressing a specific public health problem
from the past. Fifty-eight studies (35%) applied WGS in
quasi-real time, i.e., directly impacting the ongoing out-
break. In the majority of outbreak investigations, WGS
was used on a subset of available samples (n = 107, 65%),
for example, to further differentiate between isolates
assigned to the same subtype as identified by conven-
tional characterization methods. Outbreak investigations
using WGS were mainly applied to Staphylococcus aur-
eus (n = 12) and multidrug-resistant (MDR) Gram-
negative bacteria (n = 27) in a hospital setting, to Sal-
monella spp. (n = 33) and Listeria monocytogenes (n =
13) during foodborne outbreaks, and to Mycobacterium
tuberculosis (n = 14).
Van Goethem et al. Implementation Science           (2019) 14:79 Page 4 of 16
Classifying studies as control-oriented was mainly
based on the fact that these studies aimed to detect
events that require immediate action (e.g., early outbreak
detection) or that the study was initiated following a
specific public health problem. They were performed
retrospectively (n = 18, 44%), i.e., as a proof-of-concept,
and/or prospectively (n = 25, 61%). Six studies (15%) re-
ported a nation-wide implementation of prospective
genotyping into routine public health practices.
Strategy-oriented studies are in general conducted over
larger time periods and geographical areas, in order to
better understand the behavior of a certain pathogen
within a population, and to plan future prevention and
control programs. Twenty-nine studies (41%) applied
WGS to assess the impact of prevention and control pro-
grams, mostly to evaluate vaccination programs.
Genomic-informed strategy-oriented surveillance has also
been frequently applied to monitor long-term changes
over a larger geographic and population scale (n = 38,
54%) to detect the emergence of strains with enhanced
virulence, to monitor drug resistance, to detect cross-
border transmission events, or to identify zoonotic
pathogens. Studies describing the use of WGS for
strategy-oriented surveillance were often performed retro-
spectively (n = 59, 84%) on a historical subset of samples
in order to answer a specific public health question.
For control- and strategy-oriented surveillance activ-
ities, WGS was mainly applied to S. aureus (n = 23),
MDR Gram-negative bacteria (n = 16), Neisseria
meningitidis (n = 14), Salmonella spp. (n = 13), and M.
tuberculosis (n = 9).
Results of individual studies
Outbreak investigations
WGS provides increased resolution for case ascertain-
ment and linking possible sources to these cases during
outbreak investigations of food- and waterborne
pathogens compared to conventional typing methods
where only a small fraction of the genome is used (e.g.,
pulsed-field gel electrophoresis [PFGE], multiple-locus
variable-number tandem-repeat analysis [MLVA], and
multi-locus sequence typing [MLST]). The discrimin-
atory power of WGS allows heterogeneous clusters of
isolates, often indistinguishable with these previously
used typing methods, to be split up into smaller groups
of cases that are more likely to originate from a common
source [21–31]. The increased resolution of WGS is
particularly useful for clonal pathogens or serotypes that
show little genetic variation [32–35]. Investigations apply-
ing WGS during the course of an outbreak were able to
identify the likely source of infection and rapidly imple-
ment control measures to stop further spread [36–42]. On
Fig. 2 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram
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several occasions, WGS data combined with epidemio-
logical investigations enabled food authorities to intervene
based on strong evidence and the subsequent timely recall
of potentially contaminated food [43–45]. Moreover, the
digital and universal nature of WGS allows data to be ex-
changed and analyzed between different countries during
multi-national outbreaks [34, 44, 46–49]. However, this
requires internationally standardized protocols and
Table 1 Characteristics of included studies (Jan 2015 to Sep 2018: n = 275)
Study characteristic No. of studies (Jan 2015 to Sep 2018)
Outbreak investigations (n =
164)
Control-oriented surveillance
(n = 41)
Strategy-oriented surveillance
(n = 70)
Country¥,*
USA and Canada 42 7 16
UK and Ireland 33 13 15
Australia and New Zealand 19 3 7
Germany 14 2 4
Denmark 9 4 0
France 5 2 2
Setting¥
Community 94 23 47
Institutional (hospital, school, nursery, etc.) 73 21 25
Time orientation of NGS analyses¥
Retrospective 97 18 59
Quasi-real time 58 0 0
Prospective 11 25 11
Level of implementation of NGS analyses¥
Proof-of-concept 57 27 8
Used to address a specific public health
problem
100 10 61
Implemented into routine public health 14 6 2
Sampling fraction of NGS analyses
All available samples 57 25 21
Subset of available samples
(complementary)
107 16 48
Pathogens¥
Staphylococcus aureus 15 10 13
Multidrug-resistant Gram-negative bacteria 27 4 12
Vancomycin-resistant Enterococci (VRE) 5 6 0
Clostridium difficile 5 1 2
Streptococcus spp. 8 0 6
Listeria monocytogenes 13 4 1
Shigella spp. 1 2 2
Salmonella spp. 33 5 8
Shiga toxin-producing Escherichia coli (STEC) 10 4 1
Campylobacter jejuni 5 0 0
Legionella spp. 10 0 1
Mycobacterium spp. 14 6 5
Neisseria spp. 6 0 14
Others 13 1 6
¥One study can be assigned to multiple categories
*Non-exhaustive list
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nomenclature, as well as meaningful interpretation guide-
lines [32]. In addition to rapid source tracing, WGS pro-
vides insights into the virulome of certain pathogenic
clades [50–53]. For example, real-time WGS is able to
generate timely information concerning the presence of
virulence genes during a Shiga toxin-producing Escheri-
chia coli (STEC) outbreak [51]. WGS was often used to
guide nosocomial outbreak investigations. It was reported
several times that transmission events that were suspected
based on epidemiological data alone or using low-
resolution strain typing methods like antibiogram profiles
had been disproved by integrating WGS data [54–57].
The ability to quickly exclude a patient or potential source
during an outbreak investigation is equally important for
infection control purposes as the confirmation of related
isolates [39], thereby preventing inappropriate, costly, and
ineffective control measures [55, 56].
The most highlighted issue is the fact that WGS, as is
equally the case for conventional typing methods, cannot
stand on its own and that epidemiological data (includ-
ing time, place, and exposure data) should complement
the WGS results to identify a common source or link
cases during outbreak investigations [24, 58–64]. False
conclusions could be drawn from WGS data alone since
it is possible that epidemiologically unrelated isolates are
highly similar at the SNP level [58, 65–67]. Another
reported issue was the potential misinterpretation of iso-
late relationships given the diversity of isolates that can
be found within a single host (e.g., following long term
carriage) or environmental reservoir. It was stressed by
several studies that it is important to account for this
“cloud of diversity” by increasing the number of samples
taken from the suspected source [55, 66–73]. On the
other hand, within-host diversity allows to identify long-
term carriers [74].
Control-oriented surveillance
Several public health agencies launched pilot projects to
implement WGS in routine practice for control-oriented
surveillance purposes, such as early outbreak detection,
and evaluated its performance [75–77]. In 2013, a multi-
agency collaboration prospectively performed WGS on
all available L. monocytogenes isolates collected from pa-
tients, food, and food processing environments in the
USA. Implementation of WGS data into their surveil-
lance activities led to the detection of an increased num-
ber of outbreak clusters. In addition, combining WGS
data with robust epidemiological information solved
more outbreaks compared to before with PFGE [77].
Retrospective comparisons during the transition period
from traditional to WGS-based characterization were
not considered an obstacle given the possibility to
accurately extract traditional typing information for L.
monocytogenes from WGS data [75]. Also for STEC
O157, the added value of implementing WGS as a tool
to inform national surveillance was demonstrated as it
led to early and accurate outbreak detection [78], as well
as the ability to extract information concerning import-
ant virulence determinants and monitor the emergence
of hyper-virulent strains [79, 80]. Similarly, a prospective
trial of sequencing all Salmonella Typhimurium isolates
concurrently with the conventional MLVA typing tech-
nique in Australia demonstrated the higher resolution
offered by WGS leading to better source attributions
and more targeted epidemiological investigations [81].
However, several challenges related to the interpretation
of WGS data remain. As for outbreak investigations, it
was reported several times that WGS results should not
be interpreted on their own. A single cutoff of the
number of SNPs to assess relatedness cannot consist-
ently predict whether isolates are epidemiologically
linked [77, 81–83]. However, field data (e.g., demo-
graphic data or exposure histories) are only valuable
when organized in a standardized format, requiring a
more systematic approach to epidemiological data
collection [84]. Another implementation barrier reported
was the limited capacity of the public health unit to
understand and use WGS data, implying an increased
need for collaboration and exchange of expertise
between microbiologists, bioinformaticians, and epide-
miologists [81].
NGS has been applied to monitor antimicrobial
resistance of hospital-acquired infections. Genotypic
prediction of resistance of S. aureus strains seems at
least as reliable as routine phenotypic testing. However,
Table 2 Study aims (applications of NGS) of included studies
(Jan 2015 to Sep 2018: n = 275)
Study aim(s)
Outbreak investigations (n = 164)
Source tracing 78
Identify transmission routes 85
Inform outbreak management: feedback on key
phenotypic attributes
11
Control-oriented surveillance (n = 41)
Understand transmission dynamics (identify
transmission networks/clusters)
15
Early outbreak detection 23
Overview of circulating strains to identify the
emergence of new threats
12
Strategy-oriented surveillance (n = 70)
Understand transmission dynamics to develop
prevention strategies
21
Overview of circulating strains (long-term trends) 38
Impact assessment of prevention and control programs 29
Identification of risk factors and risk groups 6
One study can have multiple study aims
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phenotypic prediction based on the genotype cannot re-
place phenotypic testing, as the present understanding
of the genetic basis of resistance and the associated data-
bases are not comprehensive [85]. This limitation was
shown during a WGS-based surveillance of antimicro-
bial resistant determinants in Klebsiella pneumonia
where the phenotypically determined resistance was
higher than the sequenced-based resistance [86].
WGS has proven to be a more reliable tool to predict
epidemiological links between tuberculosis cases than
the conventional variable number of tandem repeat
(VNTR) genotyping that often lead to false cluster
identification [87]. WGS as a tool for the identification
of tuberculosis outbreaks may be particularly useful in
settings where the genetic diversity is expected to be
lower such as geographically restricted M. tuberculosis
populations [88], genetically closely related genotypes
imported from a high-incidence region [89], or for
highly monomorphic M. tuberculosis lineages [90].
Strategy-oriented surveillance
Several studies showed the value of WGS in understand-
ing the impact of vaccination on circulating pathogen
populations, potentially resulting in antigenic drift to
escape vaccine-mediated immune selective pressure (i.e.,
strain replacement) [91–100]. Gaining insights into this
is achieved by comparing the incidence of infections
caused by vaccine targeted serotypes before and after the
introduction of the vaccine, and to potentially identify
the proliferation of non-vaccine targeted strains. The
adoption of WGS methods to monitor pathogen popula-
tions during immunization programs has proven to be
useful and could potentially identify differential impacts
on distinct serotypes [91]. Genomic surveillance pro-
vides the required resolution for the development of tar-
geted interventions [92] and to predict the impact of
implementing a vaccination program in a given popula-
tion [101]. The routine use of WGS for surveillance
purposes can also inform antibiotic stewardship. One
advantage of introducing WGS to inform treatment
guidelines is the ability to identify genetically linked
resistance that can be co-selected by multiple drugs, as
opposed to phenotypic resistance rates that consider
each antimicrobial class as a discrete unit [102]. In
addition, resistance rates can vary significantly by clone
implying that monitoring changes in population struc-
ture using WGS is useful to guide antibiotic usage
policies [103]. Besides informing vaccination programs
and antibiotic stewardship, WGS can reveal a detailed
understanding of the transmission dynamics within and
between healthcare settings, the community, and indi-
vidual households, to appropriately direct control pro-
grams and decolonization strategies [104–112].
Several studies highlighted the public health benefits of
WGS-guided surveillance to monitor the spread of
multidrug-resistant isolates and mobile genes, including
resistance-carrying transposons and plasmids that are able
to transfer resistance between bacterial species [113–118].
The zoonotic potential of clinically relevant multi-resistant
bacteria stresses the importance of the ‘One Health’ ap-
proach. In general, WGS-informed surveillance including
isolates from different hosts and settings can provide evi-
dence for interspecies transmission and focus control ef-
forts on important reservoirs [119–126].
Reported challenges, issues, and obstacles from an
epidemiologist’s perspective
Several studies reported challenges, issues, and obstacles
(not exclusively) related to the integration of pathogen
genomics within the activities of epidemiologists. For ex-
ample, the inability to link laboratory and contextual
data due to missing unique identifiers [127] impedes
proper data integration. Further, contextual data was
often missing, limited, or unstandardized [30, 34, 38, 49,
62, 71, 84, 94, 108, 128–140]. Regarding the sampling
strategy, selection bias might arise when WGS has been
performed on a small proportion of cases/isolates, severe
cases are overrepresented among sequenced isolates,
asymptomatic cases/carriers are excluded, or certain
geographical regions or time periods are overrepresented
[24, 30, 32, 52, 59, 85, 91, 93, 106, 116, 128, 141–144].
In addition, there might be insufficient statistical power
to detect associations due to a low number of sequenced
strains [81, 128, 144, 145].
Discussion
Applications
Within the set of studies included in this scoping review,
NGS was mainly used as a tool to provide information
on the whole genome of the bacterial pathogens. WGS
has useful applications in both outbreak investigations
and surveillance activities. Outbreak investigations bene-
fit from the increased resolution offered by WGS for
case ascertainment, linking cases to the possible sources,
defining transmission clusters, and providing rapid feed-
back on key phenotypic attributes of the involved patho-
gens. The application of WGS during control-oriented
surveillance was mainly aimed at early outbreak detec-
tion by accurately defining transmission clusters among
circulating strains, unraveling transmission chains to
guide targeted interventions, and identifying the emer-
gence of new threats. The use of WGS during strategy-
oriented surveillance seemed particularly useful to assess
the impact of prevention and control programs, such as
vaccination campaigns and antibiotic stewardship.
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Level of implementation
WGS has been increasingly used as a typing tool for
comparison of isolates during outbreak investigations.
Most published studies were retrospective (59%), but an
increasing number applied WGS in quasi-real time. For
surveillance activities of certain pathogens, there has
been a shift from proof-of-concept studies to routine
use of WGS. In several countries, public health agencies
and regulatory bodies [e.g., Public Health England, US
Centers for Disease Prevention and Control (CDC),
European Food Safety Authority (EFSA)] have imple-
mented WGS as a routine typing tool for surveillance
activities of selected pathogens. Although WGS is (or
was) mainly used in parallel with conventional testing in
many European countries [76, 81, 82, 87, 146], countries
such as Denmark, France, and the UK have already
transitioned completely to WGS for certain pathogens
[34, 43, 46, 76, 84, 147–150]. Following the results of a
survey conducted by ECDC, 20 countries (i.e., two thirds
of European Union and European Economic Area coun-
tries) were routinely using WGS in 2017 for national
surveillance of at least one human pathogen [151].
Added value
WGS has shown superior sensitivity and specificity to
identify transmission clusters compared to traditional
subtyping methods such as PFGE, MLVA, and MLST
that often do not provide the required resolution to dis-
criminate between outbreak-related and sporadic cases
[21–31, 59]. Thanks to its greater specificity, WGS al-
lows to reject a false hypothesis of transmission gener-
ated by conventional methods, thereby avoiding
inappropriate, costly, and ineffective follow-up investiga-
tions and control measures [39, 55, 56, 78, 152]. More
targeted interventions can save resources at the health
protection and local authority level [78]. The major
advantage of implementing WGS during surveillance
activities or outbreak investigations is therefore inherent
in the higher resolution of the WGS output itself. It
should be noted that the utility of WGS varies depend-
ing on the public health objective (discriminating be-
tween closely related individual cases during a point-
source outbreak or national surveillance purposes) [153],
as well as on the population structure (high incidence
settings versus low-transmission settings) [88, 89] and
the clonality of the pathogen [32–35, 90]. Also, a step-
wise implementation of typing methods has proven to
be a useful approach. Conventional molecular methods
can serve as a first-level classification to confine possible
outbreak isolates. At the next level, WGS can bring
deeper and more comprehensive insights [130, 154].
In terms of technical advantages, WGS is a universal
test that is applicable to all organisms [155] and has the
potential to provide multiple tests in silico (e.g., antibiotic
resistance, serotype, virulence genes) from a single assay,
thereby replacing several conventional methods and/or
providing additional information on the studied pathogen
[57, 79, 156, 157]. Therefore, NGS is able to replace
current time-consuming and labor-intensive methods with
a single, all-inclusive diagnostic test [94, 157, 158].
Moreover, the digital nature and the reliability of WGS
data allow exchange and to compare data across countries
[44, 46, 47]. The development of shared databases will
make it increasingly possible to establish links between
sequences from different countries and sources.
Challenges, issues, and obstacles
Definition of a cluster
The main issue reported when using WGS data to detect
and to confirm transmission between isolates was the
difficulty, if not impossibility, to define with a single
SNP/allele threshold how much genetic variation can
exist within an epidemiologically related cluster [1, 23,
28, 57, 58, 65, 67, 159]. The number of SNPs within a
cluster often depends on various factors, such as the
genetic diversity within each species, its molecular clock,
evolutionary forces, the nature of the outbreak (point-
source, long-lasting, multinational, etc.), the extent of di-
versity in the background population, within-host diver-
sity, the population bottleneck during transmission, the
level of asymptomatic infections, the number of isolates
included in the analysis, and the methods used for gen-
omic analysis [1, 25, 67, 74, 81, 83, 147, 160–162]. Many
studies stress the fact that we cannot rely solely on
genomic information during outbreak investigations or
surveillance activities and that epidemiological data de-
scribing the temporal and spatial dynamics of infection
should always be considered [59–61, 63, 67, 77, 81–83].
Contextual data should therefore be collected carefully
and combined with WGS data for a proper interpret-
ation, which is almost seamlessly linked to the challenge
of data integration.
Data integration
A useful interpretation of genomic data is highly
dependent on the epidemiological and clinical metadata
[1, 160, 163, 164]. The integration of laboratory and
epidemiological data is often hampered by the incom-
plete and/or unstructured nature of the contextual data
[13, 84, 128, 165]. For example, during a multi-country
outbreak investigation, it is important to develop a code-
book for uniform and standardized data entry between
countries [34, 49]. To maximize the potential of WGS,
public health professionals have to identify a minimum
set of variables (such as time, place of infection, host
characteristics, clinical presentation, and exposures) that
should be incorporated within surveillance activities of a
particular pathogen [165].
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Although WGS data has the potential to support
phenotypic predictions of virulence and resistance based
on the genotype, phenotypic data will still be needed to
identify new resistance/virulence mechanisms and to
keep the databases up-to-date [12, 85, 86, 157, 166, 167].
Therefore, phenotypic testing results and clinical data
have to be collected in a standardized manner alongside
the sequence data to feed the databases from which as-
sociations between genotype and phenotype can be ob-
served [160].
More recently, digital streams (also called “Internet of
things”) are being used as an input for surveillance sys-
tems (i.e., digital epidemiology). Examples include search
engines, social media, mobile phones, and health trackers.
These novel data streams, generated outside public health,
could potentially enrich epidemiology by providing
information on natural and social phenomena [168].
One Health, the concept of structured collaboration
and coordination between human, animal, and eco
health systems, has become an emerging focus due to
the increased understanding of how animal and eco-
logical reservoirs significantly influence human health
[169]. Therefore, the management of infectious diseases
requires sampling from different hosts and sources. As
indicated by Rantsiou et al., the development of WGS is
currently not at the same level in the food industry as
compared to public health agencies [170]. The outputs
produced by the different sectors should remain com-
parable at any time to ensure the linkage of isolates.
An overview of data integration is presented in Fig. 3.
Collaboration between the different stakeholders
Following the previous section addressing the import-
ance of data integration, it is clear that the switch to
WGS requires an increase in multi-disciplinary working
[9, 81, 148, 171]. In particular for data interpretation,
expertise in bioinformatics and in biological, epidemio-
logical, and microbiological sciences needs to be com-
bined. Infectious disease epidemiologists implementing
WGS data into their routine workflow might need
training in genomics as well as skills in analyzing high-
dimensional data sets. In addition to interdisciplinary
and inter-sectoral (One Health) collaboration, the
implementation of WGS should be coordinated at an
international level as infectious diseases do not respect
national boundaries [49].
Sampling frame
As for any type of epidemiological study, genomics-
informed surveillance activities should be based on
robust sampling strategies defining the required sample
size and the number of samples needed from the differ-
ent sources. The sampling framework will vary
Fig. 3 Integration of multiple data types. The anticipated workflow of infection prevention and control includes the following: (1) samples are
obtained from cases infected with a certain pathogen, as well as from other sources such as the environment, food, and/or animals following the One
Health approach; (2) pathogens are isolated, and information concerning the biological characteristics is obtained through classical microbiological
testing. Phenotypic tests are still required to feed databases and confirm genotype-phenotype associations. Culturing steps (isolation) are often
preceding genome sequencing; however, sequencing directly from clinical samples is also possible using culture-independent methods
(metagenomics); (3) high-throughput sequence data is generated (other -omics technologies such as transcriptomics, proteomics, and metabolomics
can complement the genomic information); (4) relationships among isolates and specific characteristics are inferred based on sequence information
obtained through bioinformatics tools; (5) to come to a meaningful outcome (i.e., transmission chains, cluster identification, source tracing, key
phenotypic attributes), the genomic evidence is combined with epidemiological metadata (time, place, exposures, etc.) from field epidemiological
investigations, clinical data obtained through the healthcare system, biological characteristics obtained through classic microbiological methods, and
big data on natural and social factors. Finally, infection prevention and control measures can be conducted on the basis of this
aggregated information
Van Goethem et al. Implementation Science           (2019) 14:79 Page 10 of 16
depending on the type of public health application (e.g.,
investigating an explosive outbreak often requires dense
sampling including multiple samples from single
sources, as opposed to strategy-oriented surveillance re-
quiring a representative coverage of the population)
[171]. Selection bias can be introduced when the subset of
samples selected for WGS is not representative [128, 163].
In order to efficiently assemble a representative sample, it
is often needed to develop a stratified sampling scheme
according to time, place, and person, or to perform
normalizations to maintain original sampling fractions.
Translational research and information overload
Genomic information must be interpreted and translated
in a meaningful manner into both immediate public
health action and longer term prevention programs [2,
57, 172]. Moving from low-resolution typing methods to
WGS-based typing will lead to an increase in the
detected number of hazards. Not only will the sensitive
nature of WGS increase the number of clusters detected
[76, 77], it will also provide additional information on
the presence of resistance genes, virulence genes, etc. It
will be important to filter out the hazards that are truly
relevant from a public health point of view (i.e., separate
the “signal” from the “noise”) and that subsequently
require the initiation of a public health action.
Limitations of the scoping review
A possible limitation is the fact that only studies pub-
lished after 2015 were included. However, NGS is a fast-
evolving technique, and we were mainly interested in its
state-of-the-art applications. Another potential limitation
is that only one database (PubMed) was searched. How-
ever, hand searching and reference checking were ap-
plied to partly account for this. Still, it is likely that
additional publications exist outside this search. Some
work will have been missed, but the aim was to have a
systematic overview of the field rather than an exhaust-
ive capture of every single published article. An encoun-
tered difficulty during the selection process was the
subjective nature of the inclusion and exclusion criteria,
mainly in terms of classifying the studies according to
their context (public health, research, or diagnostics).
We tried to account for this by screening the full texts
by two independent reviewers. Further, data extraction
was based only on the data provided in the individual
studies and, if available, supplementary information.
Although the data extraction was performed using a
standard procedure, it is possible that some information
was misinterpreted. Given the large number of included
studies, it was opted not to contact the investigators to
retrieve additional data.
Future perspectives
Currently, the most common strategy to integrate WGS
into routine public health surveillance is to add genomic
typing to conventional surveillance activities where an
increased resolution is considered necessary, i.e., on a se-
lected subset of isolates. As costs will drop, microbiology
laboratories will potentially implement WGS in their
routine workflow. Following this scenario, the use of
WGS is foreseen for all clinical isolates and the number
of isolates sequenced would no longer be driven by pre-
determined study designs [157, 163]. This way, sequence
data gathered for diagnostic purposes can be accumu-
lated for public health activities. In addition, large-scale
research into genotype-phenotype associations from
routinely collected data will be possible [157].
Conclusions
This scoping review addresses the current state and
potential of implementing pathogen genomics for rou-
tine public health practice. Main applications include the
use of WGS data for (1) source tracing during outbreak
investigations, (2) early outbreak detection, (3) unravel-
ing transmission dynamics in order to implement
targeted interventions, (4) monitoring drug resistance,
(5) detecting cross-border transmission events, (6) iden-
tifying the emergence of strains with enhanced virulence
or strains with zoonotic potential, and (7) assessing the
impact of prevention and control programs, such as
vaccination campaigns. The main reported added value
of WGS by the included studies is the superior reso-
lution compared to the conventional methods, and con-
sequently being able to accurately confirm or rule out
transmission events. However, it should be emphasized
that WGS cannot stand on its own and should be inte-
grated with other data types. High-quality epidemio-
logical data and study designs are needed to realize the
full potential of WGS. Collaborations between infectious
disease epidemiologists, public health practitioners,
microbiologists, and bioinformaticians are key for a
successful genomics-informed surveillance.
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